Acute or
Preventive
Both acute and preventive
Delivery Method
Oral disintegrating tablet
Dosage
1 tablet every other day for prevention OR 1 tablet as needed for acute treatment, not to exceed 1 tablet in 24 hours
Most Common Side Effects
Nausea, stomach pain, indigestion
Savings Program Availability
Eligible commercially insured patients can pay $0 per month
Coverage under Medicare and Medicaid varies
How Many Doses per Month?
8–16
(1 box contains 8 doses)
Efficacy in
Clinical Trials
Aborted 21% of attacks as an acute med
Reduced monthly migraine days by 4–3 when used for prevention
Minimum Eligible Age
18 years old
Rimegepant (Nurtec)
Atogepant (Qulipta)
Ubrogepant (Ubrelvy)
Zavegepant (Zavzpret)
Preventive
Eligible commercially insured patients can pay $0 per month
Coverage under Medicare and Medicaid varies
1 tablet every day for prevention
Reduced monthly migraine days by 2-4 for episodic migraine
Reduced monthly migraine days by 7 for chronic migraine
Oral pill
Nausea, constipation, loss of appetite, fatigue/sleepiness
30
18 years old
Acute
Eligible commercially insured patients can pay $0 per month
Coverage under Medicare and Medicaid varies
1 spray in either nostril; not to exceed 1 spray per 24 hours
Aborted 24% of attacks
Nasal spray
Unusual taste, nausea,
nasal discomfort,
and vomiting
6
18 years old
Acute
Eligible commercially insured patients can pay $0 per month
$2.43 is the average cost for a 30-day supply under Medicaid
$24 is the average cost for a 30-day supply under Medicare Part D
1 tablet as needed for acute treatment;
can take a second tablet 1 hour after the first if needed
A dose of 50 milligrams aborted 19.2% of attacks
A dose of 100 milligrams aborted 21.2% of attacks
Oral pill
Nausea, sleepiness
10–20 pills
(1 box contains 10 pills. Some patients need 2 pills per dose)
18 years old
Acute or
Preventive
Both acute and preventive
Delivery Method
Oral disintegrating tablet
Dosage
1 tablet every other day for prevention OR 1 tablet as needed for acute treatment, not to exceed 1 tablet in 24 hours
Most Common Side Effects
Nausea, stomach pain, indigestion
Savings Program Availability
Eligible commercially insured patients can pay $0 per month.
Coverage under Medicare and Medicaid varies.
How Many Doses per Month?
8-16
(1 box contains 8 doses)
Efficacy in
Clinical Trials
Aborted 21% of attacks as an
acute med.
Reduced monthly migraine days by 4.3 when used for prevention.
Minimum Eligible Age
18 years old
Rimegepant (Nurtec)
Atogepant (Qulipta)
Ubrogepant (Ubrelvy)
Zavegepant (Zavzpret)
Preventive
Eligible commercially insured patients can pay $0 per month.
Coverage under Medicare and Medicaid varies.
1 tablet every day for prevention
Reduced monthly migraine days by 2-4 for episodic migraine.
Reduced monthly migraine days by 7 for chronic migraine.
Oral pill
Nausea, constipation, loss of appetite, fatigue/sleepiness
30
18 years old
Acute
Eligible commercially insured patients can pay $0 per month.
Coverage under Medicare and Medicaid varies.
1 spray in each nostril as needed
Aborted 24% of attacks
Nasal spray
Unusual taste, nausea,
nasal discomfort,
and vomiting
6
18 years old
Acute
Eligible commercially insured patients can pay $0 per month.
$2.43 is the average cost for a 30-day supply under Medicaid.
$24 is the average cost for a 30-day supply under Medicare Part D.
1 tablet as needed for acute treatment;
can take a second tablet 1 hour after the first if needed
A dose of 50 milligrams aborted 19.2% of attacks.
A dose of 100 milligrams aborted 21.2% of attacks.
Oral pill
Nausea, sleepiness
10-20 pills
(1 box contains 10 pills. Some patients need 2 pills per dose)
18 years old